FDA Clears BresoDX1 for At-Home Sleep Apnea Testing
BresoDX1 is designed to record a patient’s physiological signals during sleep using a sensor and a pulse oximeter.
BresoDX1 is designed to record a patient’s physiological signals during sleep using a sensor and a pulse oximeter.
The approval was based on data from 2 clinical trials that compared Xenoview MRI to xenon Xe 133 scintigraphy in adults with pulmonary disorders.
Four children have become trapped in the blankets, including a 4-year-old girl and a 6-year-old girl who both died
Actemra (tocilizumab) is an interleukin-6 receptor antagonist.
Medication limits are meant to ‘ensure equitable access,’ according to a CVS statement
The ENHANCE-1 trial evaluated nebulized ensifentrine as monotherapy or as an add-on to a LAMA or a LABA in patients with moderate to severe COPD.
However, early electronic cigarette quitters plus stable cigarette use was the most common trajectory in 41.6 percent of participants
The ready-to-dilute formulation was developed to eliminate the reconstitution step with Alimta.
During the past few weeks, COVID-19, the flu, and respiratory syncytial virus have made millions of Americans ill
The table provided is a review of notable updates that occurred in November 2022 for investigational products in development.